Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.

Oncology reports - 1 Jun 2007

Arifin Marina, Hiyama Keiko, Tanimoto Keiji, Wiyono Wiwien Heru, Hiyama Eiso, Nishiyama Masahiko

Abstract excerpt

The prognosis of lung cancer remains poor, and biological heterogeneity is largely responsible, especially in adenocarcinoma. We previously found that only one third of non-small cell lung cancer (NSCLC) but most small cell lung cancer (SCLC) tissues have strong telomerase activity, representing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Chromosome Aberrations
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Retinoblastoma Protein

Share to Telomerase

Source

Identifiers

PMID: 17487398

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17487398-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.PMID 17487398Read ↗

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.Semantic proximity Read ↗

Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications.Semantic proximity Read ↗

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical OutcomesSemantic proximity Read ↗

Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.Semantic proximity Read ↗

Telomerase expression in lung preneoplasia and neoplasiaSemantic proximity Read ↗

Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk.Semantic proximity Read ↗

Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.Semantic proximity Read ↗

Evidence for Common Clonal Origin of Multifocal Lung CancersSemantic proximity Read ↗

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.